Clinical Trials

The James Cancer Center Columbus, OH

open for enrollment

Ph2 Bruton's Tyrosine Kinase Inhibitor PCI-32765 for Treatment of Relapsed Hairy Cell Leukemia

Protocol: OSU-12200

Full Title

A Multicenter Phase 2 Study of the Bruton's Tyrosine Kinase Inhibitor PCI-32765 (Ibrutinib) for Treatment of Relapsed Hairy Cell Leukemia

Leukemia Hairy Cell Leukemia